
Ocumension Therapeutics Announces 2022 Annual Results
HONG KONG, Mar 30, 2023 – (ACN Newswire via SEAPRWire.com) – Ocumension Therapeutics (“Ocumension” or the “Company”, together with its subsidiaries, collectively the “Group”, stock code: 1477), a leading China […]